FIELD: medicine.
SUBSTANCE: invention relates to field of biochemistry, in particular to antibody or its functional fragment, aimed against Staphylococcus aureus epitope, as well as to their application for Staphylococcus aureus detection. Disclosed is cell line of hybridoma, which produces said antibody, where cell line of hybridoma is cell line, deposited in DSMZ under accession number DSM ACC2987. Invention also relates to method of treatment or prevention, which contains introduction of said antibody or its functional fragment to human or animal, where treatment is treatment of infection in human or animal, where infection is caused by Staphylococcus aureus, and where prevention is prevention of such disease, caused by Staphylococcus aureus.
EFFECT: invention makes it possible to effectively treat human infection, caused by Staphylococcus aureus.
20 cl, 7 dwg, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| MONOCLONAL HUMAN ANTIBODY AGAINST ALPHA-TOXINE FROM S. AUREUS AND ITS APPLICATION IN TREATMENT OR PREVENTION OF ABSCESS FORMATION | 2010 |
|
RU2529946C9 |
| ANTIBODIES FOR SPECIFIC BINDING OF STAPHYLOCOCCUS AUREUS ALPHA-TOXIN AND METHODS OF APPLICATION | 2012 |
|
RU2620065C2 |
| ANTI-PBP2A PROTEIN MONOCLONAL ANTIBODIES AND HOMOLOGOUS SEQUENCES FOR TREATING BACTERIAL INFECTION AND IMMUNODIAGNOSIS OF Firmicutes BACTERIA | 2010 |
|
RU2575070C2 |
| COMPOSITIONS AND METHODS FOR TREATMENT AND PREVENTION OF INFECTIONS CAUSED BY STAPHYLOCOCCUS AUREUS | 2015 |
|
RU2636780C1 |
| METHODS FOR IDENTIFICATION, ISOLATION AND PRODUCTION OF ANTIGENS FOR SPECIFIC PATHOGEN | 2002 |
|
RU2289817C2 |
| PHARMACEUTICAL COMPOSITION | 2011 |
|
RU2603078C2 |
| PHOSPHO-SPECIFIC ANTIBODIES RECOGNIZING TAU | 2012 |
|
RU2639537C2 |
| COMBINATIONS OF ANTIBODIES TO STAPHYLOCOCCUS AUREUS | 2019 |
|
RU2804815C2 |
| ANTIBODIES AGAINST STAPHYLOCOCCUS AUREUS LEUKOTOXINS | 2019 |
|
RU2805969C2 |
| ANTIBODIES FOR TREATMENT OF INFECTION AND DISEASES ASSOCIATED WITH CLOSTRIDIUM DIFFICILE | 2011 |
|
RU2630663C9 |
